OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 34 citing articles:

Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?
Lujian Zhu, Qing K. Wang, Maodong Guo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 171-189
Open Access | Times Cited: 10

Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights
Akram Hoseinzadeh, Seyed‐Alireza Esmaeili, Reza Sahebi, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro
Junyu Wang, Zongmei Wu, Mengmeng Xia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167020-167020
Open Access | Times Cited: 6

Native and engineered exosomes for inflammatory disease
Xiaoyi Ma, Bingbing Liu, Limin Fan, et al.
Nano Research (2022) Vol. 16, Iss. 5, pp. 6991-7006
Open Access | Times Cited: 24

Advances in Mesenchymal stem cells regulating macrophage polarization and treatment of sepsis-induced liver injury
Yuhao Chen, Lihong Yang, Xihong Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14

Regulation of vascular endothelial integrity by mesenchymal stem cell extracellular vesicles after hemorrhagic shock and trauma
Mark Barry, Alpa Trivedi, Byron Miyazawa, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Advances in the application of extracellular vesicles derived from three-dimensional culture of stem cells
Wenya Chen, Peipei Wu, Can Jin, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases
Yuting Tang, Peipei Wu, Linli Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
Lijun Chen, Ning Zhang, Yuqi Huang, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2192-2224
Closed Access | Times Cited: 8

Strategies to improve the therapeutic efficacy of mesenchymal stem cell‐derived extracellular vesicle (MSC-EV): a promising cell-free therapy for liver disease
Lijuan Zheng, Hui Gong, Jing Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 8

Extracellular vesicles derived from bone marrow mesenchymal stem cells ameliorate chronic liver damage via microRNA-136-5p
Xiaodan Jiang, Zhejun Liu, Hongjie You, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 3

Physical exercise in liver diseases
Yunwei Zhang, Chunyan Cao, Chaofan Li, et al.
Hepatology (2024)
Open Access | Times Cited: 3

Innate immunity and immunotherapy for hemorrhagic shock
Qingxia Huang, Song Gao, Yao Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13

Extracellular Vesicles and Their Correlation with Inflammatory Factors in an Experimental Model of Steatotic Liver Disease Associated with Metabolic Dysfunction
Melina Belén Keingeski, Larisse Longo, Vitória Brum da Silva Nunes, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 5, pp. 394-401
Closed Access | Times Cited: 2

Mesenchymal stem cell therapy for liver transplantation: clinical progress and immunomodulatory properties
Fuli Wen, Guokai Yang, Saihua Yu, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
Jinsol Han, Chanbin Lee, Jin Hur, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 22-22
Open Access | Times Cited: 11

Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models
Xinru Fang, Feiqiong Gao, Qigu Yao, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 441-441
Open Access | Times Cited: 6

Therapeutic potentials of mesenchymal stromal cells-derived extracellular vesicles in liver failure and marginal liver graft rehabilitation: a scoping review
Alexandre Sitbon, Pierre-Romain Delmotte, Claire Goumard, et al.
Minerva Anestesiologica (2023) Vol. 89, Iss. 7-8
Closed Access | Times Cited: 6

Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
И. В. Холоденко, K. N. Yarygin
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3056-3056
Open Access | Times Cited: 6

Mesenchymal stem cells overexpressing PBX1 alleviates haemorrhagic shock-induced kidney damage by inhibiting NF-κB activation
Di Jia, Jiahui Han, Jimin Cai, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1871, Iss. 1, pp. 119571-119571
Open Access | Times Cited: 5

Global scientific trends on the immunomodulation of mesenchymal stem cells in the 21st century: A bibliometric and visualized analysis
Zhongqing Wang, Yuqiang Sun, Rou Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top